Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Cancer-associated fibroblasts as a target in head and neck squamous cell carcinoma: bridging mechanisms to therapy with drugs, adjuvants, and nanotechnology
Saved in:
| Published in: | Discover Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Cancer-associated fibroblasts as a target in head and neck squamous cell carcinoma: bridging mechanisms to therapy with drugs, adjuvants, and nanotechnology
- Oncogene amplification of CCND1 via extrachromosomal DNA impacts overall survival in head and neck squamous cell carcinoma
- Post-radiation hypothyroidism in patients with head and neck tumors: An overview assessment
- ASAP3 activates the NF-κB signaling pathway to promote the progression of esophageal squamous cell carcinoma
- Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)
- Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics
- Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression